Publications

Macoir, J., Fossard, M., Nespoulous, J., Démonet, J. & Bachoud-Levi, A. (2010). The application of rules in morphology, syntax and number processing: a case of selective deficit of procedural or executive mechanisms? Neurocase, 16(4), 358-76. doi:10.1080/13554791003620272

Mallet, L., Schüpbach, M., N'Diaye, K., Remy, P., Bardinet, E., Czernecki, V., Welter, M., Pelissolo, A., Ruberg, M., Agid, Y. & Yelnik, J. (2007). Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proceedings of the National Academy of Sciences of the United States of America, 104(25), 10661-6. doi:10.1073/pnas.0610849104

Mangin, J., Rivière, D., Duchesnay, E., Cointepas, Y., Gaura, V., Verny, C., Damier, P., Krystkowiak, P., Bachoud-Levi, A., Hantraye, P., Remy, P. & Douaud, G. (2020). Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes. Neuroimage-Clinical, 26, 102211. doi:10.1016/j.nicl.2020.102211

Mariani, L., Tesson, C., Charles, P., Cazeneuve, C., Hahn, V., Youssov, K., Freeman, L., Grabli, D., Roze, E., Noël, S., Peuvion, J., Bachoud-Levi, A., Brice, A., Stevanin, G. & Durr, A. (2016). Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach. JAMA neurology, 73(9), 1105-14. doi:10.1001/jamaneurol.2016.2215

Matthys, A., Seddik, L. , Djellaoui, A. , Faugeras, F., Abdelhedi, J. , Petit, A. , Boyer, J. , Montillot, J., Hosseini, H. & Bachoud-Levi, A. (2020). Forme inflammatoire d’angiopathie amyloïde : à propos d’un cas. Revue Neurologique, 176, S71-S72

Mestre, T., Van Duijn, E., Davis, A., Bachoud-Levi, A., Busse, M., Anderson, K., Ferreira, J., Mahlknecht, P., Tumas, V., Sampaio, C., Goetz, C., Cubo, E., Stebbins, G., Martinez-Martin, P. & Members Of The Mds Committee On Rating Scales, D. (2017). Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations". Movement disorders : official journal of the Movement Disorder Society, 32(3), 482. doi:10.1002/mds.26954

Mestre, T., Bachoud-Levi, A., Marinus, J., Stout, J., Paulsen, J., Como, P., Duff, K., Sampaio, C., Goetz, C., Cubo, E., Stebbins, G., Martinez-Martin, P. & Members Of The Mds Committee On Rating Scales, D. (2018). Rating scales for Cognition in Huntington's disease: Critique and recommendations. Movement disorders : official journal of the Movement Disorder Society, 33(3), 187-195. doi:10.1002/mds.27227

Montillot, J., Salhi, H., Massart, R., Hernandez, N., Lunven, M., Fenelon, G. & Bachoud-Levi, A. (2020). Short digitalized cognitive test help differentiating Parkinson’s disease (PD) patients with and without Mild Cognitive Impairment (MCI) Mov.Disord., 35

Moss, D., Pardiñas , A., Langbehn, D., Leavitt, B., Roos, R., Durr, A., Mead, S., Track-Hd, i., Registry, i., Holmans, P., Jones, L., Tabrizi, S. & Bachoud-Levi, A. (2017). Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. Lancet Neurol., 16(9), 701-711. doi:10.1016/S1474-4422(17)30161-8

NGuyen, R. , Gravier, A. , Lesoil, C. , Bedet, A., Petit-Hoang, C. , Mahevas, M., Mekontso Dessap, A., Hodel, J. , Bachoud-Levi, A. & Cleret de Langavant, L. (2020). Acute Hippocampal Encephalopathy in Heavy Cannabis Users: About 2 Cases. The American Journal of Medicine(7), e360-e364. doi:10.1016/j.amjmed.2019.11.018

Palfi, S., Gurruchaga, J., Ralph, G., Lepetit, H., Lavisse, S., Buttery, P., Watts, C., Miskin, J., Kelleher, M., Deeley, S., Iwamuro, H., Lefaucheur, J., Thiriez, C., Fenelon, G., Lucas, C., Brugières, P., Gabriel, I., Abhay, K., Drouot, X., Tani, N., Kas, A., Ghaleh, B., Le Corvoisier, P., Dolphin, P., Breen, D., Mason, S., Guzman, N., Mazarakis, N., Radcliffe, P., Harrop, R., Kingsman, S., Rascol, O., Naylor, S., Barker, R., Hantraye, P., Remy, P., Cesaro, P. & Mitrophanous, K. (2014). Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet (London, England), 383(9923), 1138-46. doi:10.1016/S0140-6736(13)61939-X

Passeri, E., Villa, C., Couette, M., Itti, E., Brugières, P., Cesaro, P., Gherardi, R., Bachoud-Levi, A. & Authier, F. (2011). Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF). Journal of inorganic biochemistry, 105(11), 1457-63. doi:10.1016/j.jinorgbio.2011.08.006

Payoux, P., Remy, P., Miloudi, M., Houeto, J., Stadler, C., Bejjani, B., Yelnik, J., Samson, Y., Rascol, O., Agid, Y. & Damier, P. (2009). Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 29(2), 235-43. doi:10.1038/jcbfm.2008.107

Payoux, P., Remy, P., Damier, P., Miloudi, M., Loubinoux, I., Pidoux, B., Gaura, V., Rascol, O., Samson, Y. & Agid, Y. (2004). Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Archives of neurology, 61(8), 1307-13. doi:10.1001/archneur.61.8.1307

Peschanski, M., Bachoud-Levi, A. & Hantraye, P. (2004). Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain : a journal of neurology, 127(Pt 6), 1219-28. doi:10.1093/brain/awh145

Peterson, M., De Gelder, B., Rapcsak, S., Gerhardstein, P. & Bachoud-Levi, A. (2000). Object memory effects on figure assignment: conscious object recognition is not necessary or sufficient. Vision Research, 40, 1549-1567. doi:10.1016/S0042-6989(00)00053-5

Pini, L., Sambatoro, F., Youssov, K., Bachoud-Levi, A., Vallesi, A. & Jacquemot, C. (2020). Striatal connectivity in premanifest Huntington disease is differentially affected by disease burden. European Journal of Neurology, 27(11), 2147-2157. doi:10.1111/ene.14423

Pini, L., Jacquemot, C., Cagnin, A., Meneghello, F., Semenza, C., Mantini, D. & Vallesi, A. (2020). Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: A systematic review. Human Brain Mapping, 1(14), 256-269. doi:10.1002/hbm.24790

Reilmann, R., McGarry, A. , Grachev, I. , Savola, J. , Borowsky, B., Eyal, E. , Gross, N. , Langbehn, D., Schubert, R. , Wickenberg, A. , Papapetropoulos, S. , Hayden, M. , Squitieri, F., Kieburtz, K. , Landwehrmeyer, G., European Huntington'S Disease, N. & Bachoud-Levi, A. (2019). Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study. The Lancet, Neurology, 18(2), 165-176 . doi:10.1016/S1474-4422(18)30391-0

Reinhard, C., Bachoud-Levi, A., Bäumer, T., Bertini, E., Brunelle, A., Buizer, A., Federico, A., Gasser, T., Groeschel, S., Hermanns, S., Klockgether, T., Krägeloh-Mann, I., Landwehrmeyer, G., Leber, I., Macaya, A., Mariotti, C., Meissner, W., Molnar, M. , Nonnekes, J., Ortigoza Escobar, J. , Pérez Dueñas, B., Renna Linton, L., Schöls, L., Schuele, R., Tijssen, M., Vandenberghe, R., Volkmer, A., Wolf, N. & Graessner, H. (2021). The European Reference Network for Rare Neurological Diseases. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.616569

Remy, P. & Samson, Y. (2003). The role of dopamine in cognition: evidence from functional imaging studies. Current opinion in neurology, 16 Suppl 2, S37-41.

Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. (2005). Decrease of dopamine and noradrenaline innervation in the limbic system of depressed Parkinson’s disease patients. Brain(128 ), 1314-1322

Remy, P., Zilbovicius, M., Degos, J., Bachoud-Levi, A., Rancurel, G., Cesaro, P. & Samson, Y. (1999). Somatosensory cortical activations are suppressed in patients with tactile extinction: a PET study. Neurology. doi:10.1212/wnl.52.3.571

Ribeiro, M., Thobois, S., Lohmann, E., Du Montcel, S., Lesage, S., Pelissolo, A., Dubois, B., Mallet, L., Pollak, P., Agid, Y., Broussolle, E., Brice, A., Remy, P. & French Parkinson'S Disease Genetics Study, G. (2009). A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 50(8), 1244-50. doi:10.2967/jnumed.109.063529

Ribeiro, M., Idbaih, A., Thomas, C., Remy, P., Martin-Duverneuil, N., Samson, Y., Donadieu, J. & Hoang-Xuan, K. (2008). 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease. Journal of neurology, 255(4), 575-80. doi:10.1007/s00415-008-0751-8

Rieu, D., Bachoud-Levi, A., Laurent, A., Jurion, E. & Dalla Barba , G. (2006). [French adaptation of the Hopkins Verbal Learning Test] Revue neurologique. doi:10.1016/s0035-3787(06)75069-x

Robotham, L., Sauter, D., Bachoud-Levi, A. & Trinkler, I. (2011). The impairment of emotion recognition in Huntington's disease extends to positive emotions. Cortex; a journal devoted to the study of the nervous system and behavior, 47(7), 880-4. doi:10.1016/j.cortex.2011.02.014

Rosser, A. & Bachoud-Levi, A. (2012). Clinical trials of neural transplantation in Huntington's disease. Progress in brain research, 200, 345-71. doi:10.1016/B978-0-444-59575-1.00016-8

Salameh , P., Farah, R., Hallit , S., Zeidan , R., Chahine, M., Asmar , R. & Hosseini, H. (2018). Self-reported history of stroke and long-term living conditions near air pollution sources: results of a national epidemiological study in Lebanon. Environ Monit Assess, 190(3), 153. doi:10.1007/s10661-018-6545-2

Saleh, N., Moutereau, S., Azulay, J., Verny, C., Simonin, C., Tranchant, C., El Hawajri, N., Bachoud-Levi, A. & Maison, P. (2010). High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology. doi:10.1212/WNL.0b013e3181e62076